Videos

Food and Drug Administration (FDA) official Michael Landa testified at a hearing on the regulation of genetically modified food ingredients. In the second panel, advocates and opponents of g…

The House convened for a legislative session.

Representative Joe Pitts (R-PA) held a roundtable discussion as part of the House Energy and Commerce Committee’s 21st Century Cures initiative. Panelists discussed the challenges facing the…

Donald Norcross (D-NJ), Alma Adams (D-NC), and David Brat (R-NC) were expected to be sworn in. Each won special elections to serve out the remaining terms of three former members until the e…

Secretary Sylvia Burwell and other government and private sector health care leaders testified about ongoing medical community efforts to improve and develop and new treatments and cures. Th…

Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and improving drug development. She outlined her concerns in the increasin…

The House debated H.R. 3522, the Employee Health Care Protection Act. The bill that allows insurance companies the option to continue offering all group-market plans until 2018. Afterwards, …

The House held a vote series on amendments, a motion to recommit, and final passage of H.R. 5078, the EPA water jurisdiction rule. The House also held a final passage vote on H.Res. 644, a b…

Officials from the National Institutes of Health, the Food and Drug Administration, and the University of Michigan Medical School testified on the state of biomedical innovation and the sear…

Witnesses testified on federal subsidies to insurance providers under the Affordable Care Act. The subsidies, also referred to as “risk corridors,” limit health care providers' losses and ga…

The House took up H. Res. 676, which authorizes a lawsuit against President Obama for executive actions he took to delay the employer mandate in the Affordable Care Act. GOP Reps. Broun-GA, …

Following one minute speeches, the House debated five bills under suspension of the rules including H.R. 4709, a bill to develop a coordinated approach by pharmacists, industry officials, an…

The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration’s (FDA) drug development and approval process. Dr. Janet Woodcock, th…

The House debated a rule governing two bills, including H.R. 4923, the $35 billion Energy and Water Appropriations bill for fiscal year 2015.

The House convened for a legislative session.

The House debated a closed rule for H.Res. 567, establishing a select committee to investigate the Sept. 11, 2012 attack on the U.S. consulate in Benghazi

Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels as soon as the information becomes available. At …

The House convened for a legislative session.

The House convened for a legislative session.

The House debated an aid bill for Ukraine. Members also considered a year-long extension for Medicare reimbursements for physicians, and extensions of several Medicare and Medicaid payment p…